Fuan Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 15.1% in First Half of 2022

Fuan Pharmaceutical(Group) Co.,Ltd. (福安药业(集团)股份有限公司) (300194.SZ) reported a net profit of 87.7 million yuan in the first half of 2022, down 15.1% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 5.8% year-on-year.

At the end of the reporting period, it had 5.9 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 32.2%.